High doses of incobotulinumtoxinA for the treatment of post-stroke spasticity: are they safe and effective?

Andrea Santamato, Maurizio Ranieri, Vincenzo Solfrizzi, Madia Lozupone, Michele Vecchio, Antonio Daniele, Antonio Greco, Davide Seripa, Giancarlo Logroscino, Francesco Panza

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)1-4
Number of pages4
JournalExpert Opinion on Drug Metabolism and Toxicology
Publication statusAccepted/In press - Jun 18 2016


  • adverse effects
  • botulinum toxin type A
  • incobotulinumtoxinA
  • safety
  • spasticity
  • stroke
  • Upper motor neuron syndrome

ASJC Scopus subject areas

  • Toxicology
  • Pharmacology

Cite this